The Edaravone Market size is expected to grow at an annual average of 4% during 2022-2028. Edaravone is used to treat a neurological disorder called amyotrophic lateral sclerosis (ALS). It helps to slow the worsening of the disease. However, it is not a cure for ALS and does not reverse nerve damage or muscle weakness. […]
